Investing.com - Financial Markets Worldwide

Optomed PLC (OPTOMED)

Helsinki
Currency in EUR
4.05
0.00(0.00%)
Closed·
OPTOMED Scorecard
Full Analysis
Stock price movements are quite volatile
Earnings results expected in 4 days
Fair Value
Unlock Value
Day's Range
4.004.12
52 wk Range
3.107.74
Key Statistics
Edit
Prev. Close
4.05
Open
4.09
Day's Range
4-4.12
52 wk Range
3.1-7.74
Volume
14.23K
Average Volume (3m)
34.27K
1-Year Change
-36.02%
Book Value / Share
1.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPTOMED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
5.37
Upside
+32.51%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Analysts do not anticipate the company will be profitable this year
Unlock InvestingPro

Optomed PLC News & Analysis

No news in this category
Looks like there are no results in this news category

Optomed PLC Company Profile

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, and Optomed Polaris brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists’ work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. The company sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
118
Market
Finland

Compare OPTOMED to Peers and Sector

Metrics to compare
OPTOMED
Peers
Sector
Relationship
P/E Ratio
−13.4x−2.4x−0.4x
PEG Ratio
0.620.000.00
Price/Book
3.5x1.7x2.6x
Price / LTM Sales
5.1x2.0x2.9x
Upside (Analyst Target)
33.3%60.9%51.7%
Fair Value Upside
Unlock11.9%9.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.37
(+32.51% Upside)

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-0.0515 / -0.01
Revenue / Forecast
5.10M / 5.30M
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What Is the Optomed (OPTOMED) Stock Price Today?

The Optomed stock price today is 4.05

What Stock Exchange Does Optomed Trade On?

Optomed is listed and trades on the Helsinki Stock Exchange stock exchange.

What Is the Stock Symbol for Optomed?

The stock symbol for Optomed is "OPTOMED."

What Is the Optomed Market Cap?

As of today, Optomed market cap is 79.52M.

What Is Optomed's Earnings Per Share (TTM)?

The Optomed EPS (TTM) is -0.31.

When Is the Next Optomed Earnings Date?

Optomed will release its next earnings report on 27 May 2025.

From a Technical Analysis Perspective, Is OPTOMED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Optomed Stock Split?

Optomed has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.